Question

Which of the following best describes how recombinant DNA technology currently helps patients who do NOT produce adequate amounts of growth hormone (hGH)—a condition that otherwise leads to stunted growth?

a) Inserting the hGH gene into bacteria for production
b) Enhancing natural hGH production in the body
c) Blocking the hGH receptors to prevent stunted growth
d) Removing the hGH gene to prevent its expression

Answer 1

Recombinant DNA technology aids patients with hGH deficiency by inserting the hGH gene into bacteria, which then produce the hormone for medical use.

Step-by-step explanation:

The option that best describes how recombinant DNA technology currently helps patients who do not produce adequate amounts of growth hormone (hGH) is a) Inserting the hGH gene into bacteria for production. This process involves cloning the hGH gene from a cDNA library and inserting it into E.

coli cells by using a bacterial vector. The bacteria then serve as miniature factories, producing human growth hormone that can be harvested and used to treat patients with growth disorders.